Flow Cytometry Profiling of Plasmacytoid Dendritic Cell Neoplasms

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Plasmacytoid dendritic cells (pDCs) can exhibit diverse immunophenotypic presentations in various hematologic malignancies.
• Distinguishing between different pDC-associated entities is crucial for accurate diagnosis and patient management.

Purpose of the Study:

• To review the immunophenotypic spectrum of distinct entities associated with pDC proliferation.
• To provide a flow cytometry-based diagnostic strategy for these challenging conditions.
• To discuss residual disease evaluation, therapeutic challenges, and differential diagnoses.

Main Methods:

• Review of literature on pDC-associated neoplasms.
• Analysis of immunophenotypic data from flow cytometry studies.
• Discussion of diagnostic criteria and therapeutic considerations.

Main Results:

• Identified three main categories of pDC proliferation: BPDCN, MPDCP (often in CMML), and myeloid neoplasms with pDC differentiation (including pDC-AML).
• Detailed the immunophenotypic profiles characteristic of each entity.
• Highlighted the potential for pDC-like immunophenotypes in other myeloid leukemias, complicating diagnosis.

Conclusions:

• A structured flow cytometry approach is essential for diagnosing pDC-associated neoplasms.
• Understanding the immunophenotypic variability is key to differentiating these entities.
• Further research is needed to address challenges in residual disease monitoring and therapy for pDC neoplasms.